抗原激活的SOCS3+CD200R+CD4+ T细胞对利什曼原虫致病至关重要,是疫苗开发的独特靶点
研究探讨了表达SOCS3的抗原激活CD4+ T细胞表型在内脏利什曼病中的作用。小鼠模型显示,SOCS3+CD200R+CD4+ T细胞在暴露于全杀死利什曼原虫疫苗后产生更多IL-10、更少IL-12和IFN-γ。用抗CD200抗体佐剂的全杀死利什曼原虫疫苗免疫可降低脾SOCS3表达、增强CD4+ T细胞效应功能与记忆转化,并与肉芽肿和寄生虫负荷减少相关。
要点
- SOCS3+CD200R+CD4+ T细胞在利什曼原虫感染中参与细胞因子调控。
- 该亚群经全杀死利什曼原虫疫苗刺激后产生更多IL-10、更少IL-12和IFN-γ。
- 抗CD200抗体佐剂疫苗降低脾SOCS3表达并增强CD4+ T细胞效应与记忆。
核心结论
- 鉴定的SOCS3+CD200R+CD4+ T细胞亚群揭示了一种潜在的促病表型,可作为靶点增强利什曼原虫抗原的免疫原性。
研究设计与样本
- 研究采用内脏利什曼病小鼠模型,观察抗原激活的SOCS3+CD200R+CD4+ T细胞表型及其在疫苗诱导免疫中的作用。
主要发现
- 与CD200R-CD4+ T细胞相比,表达较高水平SOCS3的CD200R+CD4+ T细胞在全杀死利什曼原虫疫苗暴露后产生更多IL-10、更少IL-12和IFN-γ。
- 在利什曼原虫感染动物中阻断CD200R信号后,脾SOCS3表达及前列腺素E2等炎症因子下降。
- 用抗CD200抗体佐剂的全杀死利什曼原虫疫苗免疫不仅降低脾SOCS3表达,还增强CD4+ T细胞效应功能与记忆转化。
- 脾SOCS3下调与SOCS3低表达小鼠组肉芽肿和寄生虫负荷减少相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The expression of suppression of cytokine signalling protein (SOCS3) has been posited as a critical determinant of T cells differentiation and maturation during visceral leishmaniasis (VL), however, the antigen-activated CD4+ T cell phenotypes expressing this protein have not been explored much. Since, the inherent nature of SOCS3 protein directs the polarization of CD4+ T cells towards anti-inflammatory Th2 axis, the identification of SOCS3 expressing T-cell phenotypes will provide a better understanding on Leishmania immunobiology. Our previous findings have delineated a distinct Leishmania antigens activated CD4+ T cells phenotype expressing CD200R receptor that acts as prime anti-inflammatory disease promoting subset. Here, in this study we observed that the SOCS3+ antigen activated CD200R+CD4+ T cells phenotype is succinctly involved in cytokines regulation during Leishmania infection. We further observed that CD200R+CD4+ T cells expressing higher levels of SOCS3 protein have the potential to polarize these cells to produce more IL-10, and less IL-12 & IFN-γ as compared to CD200R-CD4+T cells on exposure to whole killed Leishmania vaccine in a mice model of VL. Furthermore, the observed decline in splenic SOCS3 expression along with inflammatory factors like prostaglandin E2, upon abrogation of CD200R signalling in Leishmania infected animals suggest a coordinated role of CD200R and SOCS3 protein in VL pathogenesis. These findings prompted us to study the potential of CD200R and SOCS3 in the vaccine-induced immunity. Immunization with an in-house whole killed Leishmania vaccine adjuvanted with anti-CD200 antibodies not only reduced splenic SOCS3 expression but also enhanced CD4+ T cells' effector functions and their memory conversion. The down-regulation of splenic SOCS3 was also found correlated with reduced granuloma and parasitic load in SOCS3-low mice groups. Hence, the identified SOCS3+CD200R+CD4+ T cells subset reveals a potential disease-promoting phenotype that can be targeted to enhance the immunogenicity of Leishmania antigens.
引用
- Singh A, Mahapatra B, Srivastava A, et al. Antigens activated SOCS3+CD200R+CD4+ T cells are critical to Leishmania pathogenesis and a distinctive target for vaccine development. Vaccine. 2025. PMID: 40660661. doi:10.1016/j.vaccine.2025.127501
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。